Cyrano Therapeutics has a total of 30 patents globally, out of which 13 have been granted. Of these 30 patents, more than 80% patents are active. United States of America is where Cyrano Therapeutics has filed the maximum number of patents, followed by Canada and Europe. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Cyrano Therapeutics.
Cyrano Therapeutics was founded in the year 2014. The Company is developing an intranasal product designed to restore function in patients with a chronic loss of taste and smell.
Do read about some of the most popular patents of Cyrano Therapeutics which have been covered by us in this article and also you can find Cyrano Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Cyrano Therapeutics patent portfolio.
How many patents does the founder and the CEO of Cyrano Therapeutics have?
The founder Robert Henkin has 1 patent and CEO Rick Geoffrion has 0 patent.
How many patents does Cyrano Therapeutics have?
Cyrano Therapeutics has a total of 30 patents globally. These patents belong to 9 unique patent families. Out of 30 patents, 24 patents are active.
How Many Patents did Cyrano Therapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Cyrano Therapeutics Applications Filed | Cyrano Therapeutics Patents Granted |
| 2023 | 4 | 1 |
| 2022 | 3 | 1 |
| 2021 | 5 | 1 |
| 2020 | – | 2 |
| 2019 | 2 | 1 |
| 2018 | 3 | – |
| 2017 | 1 | 1 |
| 2015 | 2 | 1 |
| 2014 | 2 | 1 |
| 2013 | 2 | 2 |
| 2012 | 2 | 1 |
How many Cyrano Therapeutics patents are Alive/Dead?
How Many Patents did Cyrano Therapeutics File in Different Countries?
Countries in which Cyrano Therapeutics Filed Patents
| Country | Patents |
| United States Of America | 21 |
| Canada | 1 |
| Europe | 1 |
| Hong Kong (S.A.R.) | 1 |
Where are Research Centres of Cyrano Therapeutics Patents Located?
The Research Centre for all the Cyrano Therapeutics patents is the United States of America.
10 Best Cyrano Therapeutics Patents
US8293489B2 is the most popular patent in the Cyrano Therapeutics portfolio. It has received 24 citations so far from companies like General Electric Company, Prometheus Biosciences Inc. and Immunaid Pty Ltd.
Below is the list of 10 most cited patents of Cyrano Therapeutics:
| Publication Number | Citation Count |
| US8293489B2 | 24 |
| US8663938B2 | 17 |
| US20150297601A1 | 15 |
| US8968706B2 | 14 |
| US8506934B2 | 14 |
| US8580801B2 | 12 |
| US7670849B2 | 11 |
| US20160030435A1 | 9 |
| US20180143187A1 | 6 |
| US9719988B2 | 5 |
List of Cyrano Therapeutics Patents
| Cyrano Therapeutics Patents | Title |
| US11774458B2 | Methods And Compositions For Diagnosing And Treating Loss And/Or Distortion Of Taste Or Smell |
| US11389453B2 | Compositions And Methods For Treating Chemosensory Dysfunction |
| US11125760B2 | Methods And Compositions For Diagnosing And Treating Loss And/Or Distortion Of Taste Or Smell |
| US10598672B2 | Methods And Compositions For Diagnosing And Treating Loss And/Or Distortion Of Taste Or Smell |
| US10555940B2 | Phosphodiesterase Inhibitor Treatment |
| US10206927B2 | Compostions And Methods For Treating Chemosensory Dysfunction |
| US9719988B2 | Methods For Detection Of Biological Substances |
| US8968706B2 | Methods For Diagnosing And Treating Loss Or Distortion Of Taste |
| US8663938B2 | Methods For Detection Of Biological Substances |
| US8580801B2 | Phosphodiesterase Inhibitor Treatment |
| US8506934B2 | Methods For Detection Of Biological Substances |
| US8293489B2 | Methods For Detection Of Biological Substances |
| US7670849B2 | Method For Diagnosing Insulin Resistance From Nasal Secretions |
| US20230147101A1 | Treatment Of Chemosensory Dysfunction From A Coronavirus Infection |
| US20220226332A1 | Phosphodiesterase Inhibitor Treatment |
| US20200375974A1 | Phosphodiesterase Inhibitor Treatment |
| EP4126233A1 | Treatment Of Chemosensory Dysfunction From A Coronavirus Infection |
| WO2023122473A3 | Gel Treatment For Loss Of Taste And Smell |
| WO2023122469A3 | Implants For Loss Of Taste And Smell |
| WO2023133459A1 | Nasal Spray For Phosphodiesterase Inhibitors |
| WO2023133460A1 | Improved Nasal Administration Of Pharmaceutical Formulations |
| WO2023133463A1 | Improved Nasal Administration Of Parkinson’S Therapeutics |
| CA3172275A1 | Treatment Of Chemosensory Dysfunction From A Coronavirus Infection |
| HK40084517A | Treatment Of Chemosensory Dysfunction From A Coronavirus Infection |
| US20190231785A1 | Phosphodiesterase Inhibitor Treatment |
| US20190030036A1 | Phosphodiesterase Inhibitor Treatment |
| US20180143187A1 | Methods For Detection Of Biological Substances |
| US20160030435A1 | Phosphodiesterase Inhibitor Treatment |
| US20150297601A1 | Phosphodiesterase Inhibitor Treatment |
| WO2021194893A1 | Treatment Of Chemosensory Dysfunction From A Coronavirus Infection |
What are Cyrano Therapeutics key innovation segments?
What Technologies are Covered by Cyrano Therapeutics?
The chart below distributes patents filed by Cyrano Therapeutics